These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38941280)

  • 1. Prevalence and risk factors of Hepatitis C virus infection in the Upper East Region of Ghana; a community-based cross-sectional study.
    Siaw ADJ; Amugsi J; Owusu-Konadu MAA; Drah ST; Imbeah EG; Oduro-Donkor D; Duah A; Nartey YA
    PLoS One; 2024; 19(6):e0306292. PubMed ID: 38941280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.
    Agyeman AA; Ofori-Asenso R; Mprah A; Ashiagbor G
    BMC Infect Dis; 2016 Aug; 16():391. PubMed ID: 27507267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of positive rapid diagnostic test of hepatitis C virus infection in Ghana.
    Birjandi MM; Oroei M
    Pan Afr Med J; 2020; 36():322. PubMed ID: 33193976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic overview of hepatitis C infection in the Middle East and North Africa.
    Chaabna K; Cheema S; Abraham A; Alrouh H; Lowenfels AB; Maisonneuve P; Mamtani R
    World J Gastroenterol; 2018 Jul; 24(27):3038-3054. PubMed ID: 30038471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
    Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
    Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus seroprevalence, testing, and treatment capacity in public health facilities in Ghana, 2016-2021; A multi-centre cross-sectional study.
    Nartey YA; Okine R; Seake-Kwawu A; Ghartey G; Asamoah YK; Siaw ADJ; Senya K; Duah A; Owusu-Ofori A; Adarkwa O; Agyeman S; Bampoh SA; Hiebert L; Njuguna H; Gupta N; Ward JW; Roberts LR; Bockarie AS; Awuku YA; Obiri-Yeboah D
    PLoS One; 2023; 18(6):e0287580. PubMed ID: 37352242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study.
    Kamali I; Barnhart DA; Ndahimana JD; Noor K; Mumporeze J; Nyirahabihirwe F; Gakuru JP; Musafiri T; Urusaro S; Makuza JD; Serumondo J; Rwamuhinda DD; Nkundibiza M; Kateera F; Nshogoza GR; Mubiligi JM
    PLoS One; 2021; 16(10):e0257917. PubMed ID: 34634039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence and risk factors of Hepatitis B and Hepatitis C infections among pregnant women in the Asante Akim North Municipality of the Ashanti region, Ghana; a cross sectional study.
    Ephraim R; Donko I; Sakyi SA; Ampong J; Agbodjakey H
    Afr Health Sci; 2015 Sep; 15(3):709-13. PubMed ID: 26957956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.
    Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Boamah I; Adu-Gyamfi C; Asare I; Hesse IF; Mensah G
    BMC Infect Dis; 2008 Mar; 8():33. PubMed ID: 18328097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.
    Voiculescu M; Iliescu L; Ionescu C; Micu L; Ismail G; Zilisteanu D; Radasan A; Micu G; Pertache I
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):43-8. PubMed ID: 20361074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.
    Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S
    Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study.
    Pereira LM; Martelli CM; Moreira RC; Merchan-Hamman E; Stein AT; Cardoso MR; Figueiredo GM; Montarroyos UR; Braga C; Turchi MD; Coral G; Crespo D; Lima ML; Alencar LC; Costa M; dos Santos AA; Ximenes RA
    BMC Infect Dis; 2013 Feb; 13():60. PubMed ID: 23374914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus seroprevalence and prevalence of chronic infection in the adult population in Ireland: a study of residual sera, April 2014 to February 2016.
    Garvey P; O'Grady B; Franzoni G; Bolger M; Irwin Crosby K; Connell J; Burke D; De Gascun C; Thornton L
    Euro Surveill; 2017 Jul; 22(30):. PubMed ID: 28797323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana.
    King S; Adjei-Asante K; Appiah L; Adinku D; Beloukas A; Atkins M; Sarfo SF; Chadwick D; Phillips RO; Geretti AM
    J Viral Hepat; 2015 May; 22(5):461-8. PubMed ID: 25394987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
    Shiha G; Soliman R; Mikhail NNH; Easterbrook P
    J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and trends of hepatitis C virus infection in Jordan: an observational study.
    Abu-Dayyeh I; Chemaitelly H; Ghunaim M; Hasan T; Abdelnour A; Abu-Raddad LJ
    Front Public Health; 2023; 11():1280427. PubMed ID: 38146470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of anti-hepatitis C antibody among acute febrile illness cases in Idar Taluk, Gujarat, West India.
    Nikitha S; Sabeena S; Robin S; Hiren D; Prasad V; Aswathyraj S; Devadiga S; Anup J; Arunkumar G
    Indian J Med Microbiol; 2019; 37(2):225-229. PubMed ID: 31745023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh.
    Ashraf H; Alam NH; Rothermundt C; Brooks A; Bardhan P; Hossain L; Salam MA; Hassan MS; Beglinger C; Gyr N
    BMC Infect Dis; 2010 Jul; 10():208. PubMed ID: 20630111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus (HCV) infection among patients with sickle cell disease at the Korle-Bu teaching hospital.
    Mawuli G; Dzudzor B; Tachi K; Kuma AAB; Odame-Aboagye J; Obeng BM; Boateng AT; Edu-Quansah EP; Attiku KO; Agbosu E; Arjarquah A; Bonney JHK
    Virol J; 2022 Apr; 19(1):73. PubMed ID: 35459145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.